Recommendation by the Nomination Committee concerning Board


ORION CORPORATION   STOCK EXCHANGE RELEASE 27 JANUARY 2015 at 11.40
EET


Recommendation by the Nomination Committee concerning Board of Directors to be
elected by the 2015 AGM of Orion Corporation

The Nomination Committee of Orion Corporation has given on 27 January 2015 its
recommendation to the Board of Directors of the company for the proposal to the
Annual General Meeting of 2015 concerning the composition of the Board of
Directors to be elected. The Committee recommends that the following proposal be
presented to the AGM of 2015:

The number of Board members would be seven.

The present Board members, Sirpa Jalkanen, Eero Karvonen, Timo Maasilta, Mikael
Silvennoinen, Hannu Syrjänen, Heikki Westerlund and Jukka Ylppö would be re-
elected.

Hannu Syrjänen would be re-elected as Chairman.

The Nomination Committee also announces as its recommendation that the following
remunerations be paid to the Board of Directors:

As an annual fee, the Chairman would receive EUR 76,000, the Vice Chairman would
receive EUR 51,000 and the other members would receive EUR 38,000 each. As a fee
for each meeting attended, the Chairman would receive EUR 1,200, the Vice
Chairman would receive EUR 900 and the other members would receive EUR 600 each.
The travel expenses of the Board members would be paid in accordance with
previously adopted practice. The aforementioned fees would also be paid to the
Chairmen and to the members of the committees established by the Board, for each
committee meeting attended.

Of the annual fee, 60% would be paid in cash and 40% in Orion Corporation B-
shares, which would be acquired to the members during 30 March - 2 April 2015
from the stock exchange in amounts corresponding to EUR 30,400 for the Chairman,
EUR 20,400 for the Vice Chairman and EUR 15,200 for each of the other members.
The part of the annual fee that is to be paid in cash corresponds to the
approximate sum necessary for the payment of the income taxes on the fees and
would be paid no later than 30 April 2015. The annual fees shall encompass the
full term of office of the Board of Directors.

The Nomination Committee has not given its recommendation for the remunerations
to the Board of Directors, but the matter will be proposed by a shareholder at
the AGM.

The Nomination Committee has consisted of the following members: Matti Kavetvuo,
Chairman, Kari Jussi Aho, Timo Ritakallio, Seppo Salonen, Hannu Syrjänen and
Jukka Ylppö.


Orion Corporation

 Timo Lappalainen    Olli Huotari
 President and CEO   SVP, Corporate



Contact person:
Hannu Syrjänen, Chairman of the Board of Directors of Orion Corporation
phone +358 400 454 885

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion's net sales in 2013 amounted to EUR 1,007 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.

[HUG#1889788]
Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2015 AGM of Orion Corporation
